These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 34665847)
1. Bile acid-independent protection against Clostridioides difficile infection. Aguirre AM; Yalcinkaya N; Wu Q; Swennes A; Tessier ME; Roberts P; Miyajima F; Savidge T; Sorg JA PLoS Pathog; 2021 Oct; 17(10):e1010015. PubMed ID: 34665847 [TBL] [Abstract][Full Text] [Related]
2. Functional Intestinal Bile Acid 7α-Dehydroxylation by Studer N; Desharnais L; Beutler M; Brugiroux S; Terrazos MA; Menin L; Schürch CM; McCoy KD; Kuehne SA; Minton NP; Stecher B; Bernier-Latmani R; Hapfelmeier S Front Cell Infect Microbiol; 2016; 6():191. PubMed ID: 28066726 [TBL] [Abstract][Full Text] [Related]
3. Strain-Dependent Inhibition of Clostridioides difficile by Commensal Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626 [No Abstract] [Full Text] [Related]
4. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805 [TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host. Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241 [TBL] [Abstract][Full Text] [Related]
6. Bile salt metabolism is not the only factor contributing to Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403 [TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405 [No Abstract] [Full Text] [Related]
8. Mechanisms of Colonization Resistance Against Clostridioides difficile. Pike CM; Theriot CM J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565 [TBL] [Abstract][Full Text] [Related]
9. Interactions of bile acids and the gut microbiota: learning from the differences in Cheng S; Zhu L; Faden HS Physiol Genomics; 2019 Jun; 51(6):218-223. PubMed ID: 31074701 [TBL] [Abstract][Full Text] [Related]
10. Ridinilazole, a narrow spectrum antibiotic for treatment of Qian X; Yanagi K; Kane AV; Alden N; Lei M; Snydman DR; Vickers RJ; Lee K; Thorpe CM Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G227-G237. PubMed ID: 32597706 [TBL] [Abstract][Full Text] [Related]
11. Gut associated metabolites and their roles in Aguirre AM; Sorg JA Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402 [TBL] [Abstract][Full Text] [Related]
12. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains. Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262 [TBL] [Abstract][Full Text] [Related]
14. The microbial-derived bile acid lithocholate and its epimers inhibit Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856 [No Abstract] [Full Text] [Related]
15. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855 [TBL] [Abstract][Full Text] [Related]
16. Impact of Primary and Secondary Bile Acids on Łukawska A; Mulak A Pol J Microbiol; 2022 Mar; 71(1):11-18. PubMed ID: 35635171 [TBL] [Abstract][Full Text] [Related]
17. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model. Li X; Kang Y; Huang Y; Xiao Y; Song L; Lu S; Ren Z Biomed Pharmacother; 2021 May; 137():111290. PubMed ID: 33508620 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections. Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344 [TBL] [Abstract][Full Text] [Related]
19. Review and Commentary on the Importance of Bile Acids in the Life Cycle of Clostridioides difficile in Children and Adults. Faden H J Pediatric Infect Dis Soc; 2021 May; 10(5):659-664. PubMed ID: 33626138 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of Oxo-Bile Acids and Characterization of Recombinant 12α-Hydroxysteroid Dehydrogenases from Bile Acid 7α-Dehydroxylating Human Gut Bacteria. Doden H; Sallam LA; Devendran S; Ly L; Doden G; Daniel SL; Alves JMP; Ridlon JM Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29549099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]